- Raised funding round, Jan 2015
About
XoNovo is a preclinical-stage biopharmaceutical company engaged in the development of small-molecule therapeutics for preventing the progressive loss of neuronal function across multiple neurodegenerative diseases. The company's short-term focus is on its lead drug, XN001, in support of filing an investigational new drug application for Batten disease (BD), also known as neuronal ceroid lipofuscinoses, a fatal neurodegenerative orphan disorder. XoNovo utilizes a novel approach of selective modulation of autophagy and axonal transport machinery in neurons. XN001 has been extensively tested in both in-vitro and in-vivo models, showing promising results in neurodegenerative diseases including BD, Alzheimer's disease, glioblastoma, muscular dystrophy, and tuberous sclerosis.
Funding history · 1 round · — total
Q&A
- What is XoNovo's primary focus?
- XoNovo is a preclinical-stage biopharmaceutical company focused on developing small-molecule therapeutics to prevent the progressive loss of neuronal function in neurodegenerative diseases. Their lead drug, XN001, is being developed for Batten disease (BD).
- When was XoNovo founded?
- XoNovo was founded in August 2013.
- What is the current status of XoNovo?
- XoNovo is currently inactive, having ceased operations in September 2019.
- How many employees did XoNovo have?
- XoNovo had an employee count in the 11-50 range.
- Where is XoNovo headquartered?
- XoNovo's headquarters are located in Ness Ziona, Israel.
- Who are the co-founders of XoNovo?
- The co-founders of XoNovo are Kenneth Hensley, Prof. and Rafi Gidron, Dr.
- What is XoNovo's lead drug candidate?
- XoNovo's lead drug candidate is XN001, which is being developed for Batten disease (BD).
- What approach does XoNovo use in its drug development?
- XoNovo utilizes a novel approach of selective modulation of autophagy and axonal transport machinery in neurons.
Team · 2
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/10270585 |
Identifiers & details
| Former names | FutuRx |
|---|---|
| Founded | 2013-8 |
| Employees (exact) | 30 |
| Offices | Wilmington |
| Status reason | Non Active, Sep 2019 ceased to operate |